Related Experiment Video
Updated: Oct 2, 2026
Measuring Single-Cell Mitochondrial DNA Copy Number and Heteroplasmy Using Digital Droplet Polymerase Chain Reaction
Published on: July 12, 2022
Mitochondrial DNA Copy Number Is Associated With Visual Field Progression in Primary Open-Angle Glaucoma
Purpose:
To investigate the association between mitochondrial DNA (mtDNA) copy number (CN) and the rate of visual field progression in patients with primary open-angle glaucoma.
Design:
Retrospective cohort study.
Participants:
200 patients with primary open-angle glaucoma (POAG) with a mean of 11 years of longitudinal clinical data and DNA extracted from peripheral blood.
Methods:
DNA extraction was performed on peripheral blood leukocytes collected from 200 POAG patients who had an average follow-up of 11 years. Mitochondrial CN was quantified by multiplex quantitative TaqMan PCR using custom primers and probes against cytochrome b and ß-2 microglobulin as measures of mitochondrial and nuclear genes, respectively. Univariable and multivariable linear regression models were used to evaluate the association between mtDNA CN and rates of visual field progression, quantified by the slope of standard automated perimetry (SAP) mean deviation (MD) over time.
Main Outcome Measures:
Association of mtDNA CN with MD slope.
Results:
Mean mtDNA CN was 107.6 copies per cell (interquartile range, 70.5-126.7). Higher ln(mtDNA CN) was associated with slower rates of MD loss in both univariable ( β = 0.29, p < 0.001) and multivariable analyses ( β = 0.25, p = 0.003). Higher peak IOP was independently associated with faster visual field progression in both analyses. A significant interaction was observed between mtDNA CN and peak IOP ( β = -0.054, p < 0.001), with the association between lower mtDNA CN and faster SAP progression being more pronounced at lower levels of peak IOP.
Conclusion:
Lower mtDNA CN was associated with faster SAP progression, with the association being most pronounced at lower levels of peak IOP. These findings support mtDNA CN as a potential systemic biomarker of mitochondrial genomic reserve and susceptibility to visual field loss.
